Back to Search
ISBN 9781032931319 is out of print and is currently unavailable, alternate formats (if applicable) are shown below.
Available options are listed below:

Handbook of Pharmaceutical Manufacturing Formulations: Semisolid Products (Out of print)

AUTHOR Niazi, Sarfaraz K.
PUBLISHER CRC Press (10/14/2024)
PRODUCT TYPE Paperback (Paperback)

Description

The fourth volume in the series covers the techniques and technologies involved in the preparation of semisolid products such as ointments, creams, gels, suppositories, and special topical dosage forms. Drug manufacturers need a thorough understanding of the specific requirements that regulatory agencies impose on the formulation and efficacy determination of drugs contained in these formulations.

Highlights from Semisolid Products, Volume Four include:

  • coverage of over 350 formulations
  • valuable information on the difficult area of compliance
  • changes to approved new drug applications and abbreviated new drug applications
  • the evolving guidelines of ICH and when to conduct a regulatory review
Show More
Product Format
Product Details
ISBN-13: 9781032931319
ISBN-10: 1032931310
Binding: Paperback or Softback (Trade Paperback (Us))
Content Language: English
Edition Number: 0002
More Product Details
Page Count: 370
Carton Quantity: 1
Country of Origin: US
Subject Information
BISAC Categories
Medical | Pharmacology
Medical | Chemistry - General
Descriptions, Reviews, Etc.
publisher marketing

The fourth volume in the series covers the techniques and technologies involved in the preparation of semisolid products such as ointments, creams, gels, suppositories, and special topical dosage forms. Drug manufacturers need a thorough understanding of the specific requirements that regulatory agencies impose on the formulation and efficacy determination of drugs contained in these formulations.

Highlights from Semisolid Products, Volume Four include:

  • coverage of over 350 formulations
  • valuable information on the difficult area of compliance
  • changes to approved new drug applications and abbreviated new drug applications
  • the evolving guidelines of ICH and when to conduct a regulatory review
Show More
Your Price  $61.37
Paperback